Ghrelin alleviates spinal cord injury in rats via its anti-inflammatory effects

Turkish Neurosurgery

Volumn 21, Issue 4, 2011, Pages 599-605

  Erşahin, Mehmet ^a   Toklu, Hale Zerrin ^b   Erzik, Can ^b   Akakin, Dilek ^b   Tetik, Şermin ^b   Şener, Göksel ^b   Çaǧlayan Yeǧen, Berrak ^b  

^a SAMSUN TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

Author keywords

Ghrelin; Neuroprotective; Rat; Spinal cord injury

Indexed keywords

EID: 84855829588     PISSN: 10195149     EISSN: None     Source Type: Journal    
DOI: 10.5137/1019-5149.Jtn.4736-11.0     Document Type: Article

References (50)

1. Allen A: Surgery of experimental lesion of spinal cord equivalent to crush injury of fracture dislocation of spinal column. JAMA 57:878-880, 1911.
2. Arai K, Nishida J, Hayashida K, Hatake K, Kitamura T, Miyajima A, Arai N, Yokota T: Coordinate regulation of immune and inflammatory responses by cytokines. Rinsho Byori 38: 347-353, 1990.
3. Azbill RD, Mu X, Bruce-Keller AJ, Mattson MP, Springer JE: Impaired mitochondrial function, oxidative stress and altered antioxidant enzyme activities following traumatic spinal cord injury. Brain Res 765:283-290, 1997.
4. Baldanzi G, Filigheddu N, Cutrupi S, Catapano F, Bonissoni S, Fubini A, Malan D, Baj G, Granata R, Broglio F, Papotti M, Surico N, Bussolino F, Isgaard J, Deghenghi R, Sinigaglia F, Prat M, Muccioli G, Ghigo E, Graziani A: Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 159:1029-1037, 2002.
5. Balentine JD: Pathology of experimental spinal cord trauma. I. The necrotic lesion as a function of vascular injury. Lab Invest 39:236-253, 1978.
6. Bao F, John SM, Chen Y, Mathison RD, Weaver LC: The tripeptide phenylalanine-(D) glutamate-(D) glycine modulates leukocyte infiltration and oxidative damage in rat injured spinal cord. Neuroscience 140:1011-1022, 2006.
7. Burton K: Determination of DNA concentration with diphenylamine. Methods Enzymol 12:163-166, 1968.
8. Chorny A, Anderson P, Gonzalez-Rey E, Delgado M: Ghrelin protects against experimental sepsis by inhibiting highmobility group box 1 release and by killing bacteria. J Immunol 180:8369-8377, 2008.
9. Chung H, Kim E, Lee DH, Seo S, Ju S, Lee D, Kim H, Park S: Ghrelin inhibits apoptosis in hypothalamic neuronal cells during oxygen-glucose deprivation. Endocrinology 148: 148-159, 2007.
10. Conti A, Miscusi M, Cardali S, Germano A, Suzuki H, Cuzzocrea S, Tomasello F: Nitric oxide in the injured spinal cord: Synthases cross-talk, oxidative stress and inflammation. Brain Res Rev 54:205-218, 2007.
11. Cunningham RT, Young IS, Winder J, O'Kane MJ, McKinstry S, Johnston CF, Dolan OM, Hawkins SA, Buchanan KD: Serum neurone specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction. Eur J Clin Invest 21:497-500, 1991.
12. Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, Matsukura S, Kangawa K, Nakazato M: Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141:4255-4261, 2000.
13. Delgado-Rubin de Celix A, Chowen JA, Argente J, Frago LM: Growth hormone releasing peptide-6 acts as a survival factor in glutamate-induced excitotoxicity. J Neurochem 99:839-849, 2006.
14. Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, Palaniappan R, Lillard JW, Jr, Taub DD: Ghrelin inhibits leptinand activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 114:57-66, 2004..
15. Ersahin M, Toklu HZ, Erzik C, Cetinel S, Akakin D, Velioglu-Ogunc A, Tetik S, Ozdemir ZN, Sener G, Yegen BC: The antiinflammatory and neuroprotective effects of ghrelin in subarachnoid hemorrhage-induced oxidative brain damage in rats. J Neurotrauma 27:1143-1155, 2010.
16. Fleming JC, Norenberg MD, Ramsay DA, Dekaban GA, Marcillo AE, Saenz AD, Pasquale-Styles M, Dietrich WD, Weaver LC: The cellular inflammatory response in human spinal cords after injury. Brain 129:3249-3269, 2006.
17. Florio P, Abella R, Marinoni E, Di Iorio R, Li Volti G, Galvano F, Pongiglione G, Frigiola A, Pinzauti S, Petraglia F, Gazzolo D: Biochemical markers of perinatal brain damage. Front Biosci (Schol Ed) 2:47-72, 2010.
18. Gale K, Kerasidis H, Wrathall JR: Spinal cord contusion in the rat: Behavioral analysis of functional neurologic impairment. Exp Neurol 88:123-134, 1985.
19. Gazzolo D, Abella R, Marinoni E, Di Iorio R, Li Volti G, Galvano F, Pongiglione G, Frigiola A, Bertino E, Florio P: Circulating biochemical markers of brain damage in infants complicated by ischemia reperfusion injury. Cardiovasc Hematol Agents Med Chem 7:108-126, 2009.
20. Genovese T, Cuzzocrea S: Role of free radicals and poly(ADPribose) polymerase-1 in the development of spinal cord injury: New potential therapeutic targets. Curr Med Chem 15:477-487, 2008.
21. Gonzalez-Rey E, Chorny A, Delgado M: Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology 130:1707-1720, 2006.
22. Granado M, Priego T, Martin AI, Villanua MA, Lopez-Calderon A: Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats. Am J Physiol Endocrinol Metab 288:E486-492, 2005.
23. Hattori N, Saito T, Yagyu T, Jiang BH, Kitagawa K, Inagaki C: GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. J Clin Endocrinol Metab 86:4284-4291, 2001.
24. Herrmann M, Curio N, Jost S, Wunderlich MT, Synowitz H, Wallesch CW: Protein S-100B and neuron specific enolase as early neurobiochemical markers of the severity of traumatic brain injury. Restor Neurol Neurosci 14:109-114, 1999.
25. Hillegass LM, Griswold DE, Brickson B, Albrightson-Winslow C: Assessment of myeloperoxidase activity in whole rat kidney. J Pharmacol Methods 24:285-295, 1990.
26. Hopkins SJ, Rothwell NJ: Cytokines and the nervous system. I: Expression and recognition. Trends Neurosci 18:83-88, 1995.
27. Iseri SO, Sener G, Saglam B, Ercan F, Gedik N, Yegen BC: Ghrelin alleviates biliary obstruction-induced chronic hepatic injury in rats. Regul Pept 146:73-79, 2008.
28. Iseri SO, Sener G, Yuksel M, Contuk G, Cetinel S, Gedik N, Yegen BC: Ghrelin against alendronate-induced gastric damage in rats. J Endocrinol 187:399-406, 2005.
29. Jiang H, Li LJ, Wang J, Xie JX: Ghrelin antagonizes MPTPinduced neurotoxicity to the dopaminergic neurons in mouse substantia nigra. Exp Neurol 212:532-537, 2008.
30. Kasimay O, Iseri SO, Barlas A, Bangir D, Yegen C, Arbak S, Yegen BC: Ghrelin ameliorates pancreaticobiliary inflammation and associated remote organ injury in rats. Hepatol Res 36:11-19, 2006.
31. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660, 1999.
32. Kyung KS, Gon JH, Geun KY, Sup JJ, Suk WJ, Ho KJ: 6-Shogaol, a natural product, reduces cell death and restores motor function in rat spinal cord injury. Eur J Neurosci 24:1042-1052, 2006.
33. Lee JY, Chung H, Yoo YS, Oh YJ, Oh TH, Park S, Yune TY: Inhibition of apoptotic cell death by ghrelin improves functional recovery after spinal cord injury. Endocrinology 151:3815-3826, 2010.
34. Li WG, Gavrila D, Liu X, Wang L, Gunnlaugsson S, Stoll LL, McCormick ML, Sigmund CD, Tang C, Weintraub NL: Ghrelin inhibits proinflammatory responses and nuclear factorkappaB activation in human endothelial cells. Circulation 109:2221-2226, 2004.
35. Liu NK, Zhang YP, Titsworth WL, Jiang X, Han S, Lu PH, Shields CB, Xu XM: A novel role of phospholipase A2 in mediating spinal cord secondary injury. Ann Neurol 59:606-619, 2006.
36. Liu XZ, Xu XM, Hu R, Du C, Zhang SX, McDonald JW, Dong HX, Wu YJ, Fan GS, Jacquin MF, Hsu CY, Choi DW: Neuronal and glial apoptosis after traumatic spinal cord injury. J Neurosci 17:5395-5406, 1997.
37. Miao Y, Xia Q, Hou Z, Zheng Y, Pan H, Zhu S: Ghrelin protects cortical neuron against focal ischemia/reperfusion in rats. Biochem Biophys Res Commun 359:795-800, 2007.
38. Moon M, Kim HG, Hwang L, Seo JH, Kim S, Hwang S, Lee D, Chung H, Oh MS, Lee KT, Park S: Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation. Neurotox Res 15:332-347, 2009.
39. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S: A role for ghrelin in the central regulation of feeding. Nature 409:194-198, 2001.
40. Nikulina E, Tidwell JL, Dai HN, Bregman BS, Filbin MT: The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery. Proc Natl Acad Sci U S A 101:8786-8790, 2004.
41. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG: Multiple sclerosis. N Engl J Med 343:938-952, 2000.
42. Persson L, Hardemark HG, Gustafsson J, Rundstrom G, Mendel-Hartvig I, Esscher T, Pahlman S: S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: Markers of cell damage in human central nervous system. Stroke 18:911-918, 1987.
43. Rabinowicz AL, Correale J, Boutros RB, Couldwell WT, Henderson CW, DeGiorgio CM: Neuron-specific enolase is increased after single seizures during inpatient video/EEG monitoring. Epilepsia 37:122-125, 1996.
44. Rothermundt M, Peters M, Prehn JH, Arolt V: S100B in brain damage and neurodegeneration. Microsc Res Tech 60: 614-632, 2003.
45. Scott GS, Cuzzocrea S, Genovese T, Koprowski H, Hooper DC: Uric acid protects against secondary damage after spinal cord injury. Proc Natl Acad Sci U S A 102:3483-3488, 2005.
46. Sehirli O, Sener E, Sener G, Cetinel S, Erzik C, Yegen BC: Ghrelin improves burn-induced multiple organ injury by depressing neutrophil infiltration and the release of pro-inflammatory cytokines. Peptides 29:1231-1240, 2008.
47. Shimizu Y, Nagaya N, Teranishi Y, Imazu M, Yamamoto H, Shokawa T, Kangawa K, Kohno N, Yoshizumi M: Ghrelin improves endothelial dysfunction through growth hormoneindependent mechanisms in rats. Biochem Biophys Res Commun 310:830-835, 2003.
48. Shuman SL, Bresnahan JC, Beattie MS: Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats. J Neurosci Res 50:798-808, 1997.
49. Wrathall JR, Teng YD, Choiniere D: Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-Daspartate receptors. Exp Neurol 137:119-126, 1996.
50. Young W: Spinal cord contusion models. Prog Brain Res 137:231-255, 2002.